Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome
- 1 June 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (12) , 1421-1426
- https://doi.org/10.1016/s0002-9149(03)00392-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prevalence of the Metabolic Syndrome Among US AdultsJAMA, 2002
- Weight-modification trials in older adults: what should the outcome measure be?Current Controlled Trials in Cardiovascular Medicine, 2002
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cardiovascular Morbidity and Mortality Associated With the Metabolic SyndromeDiabetes Care, 2001
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990